Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Treasury Shares (2020 - 2025)

Outset Medical (OM) has disclosed Treasury Shares for 6 consecutive years, with $203000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 11.35% to $203000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $203000.0, a 11.35% decrease, with the full-year FY2025 number at $203000.0, down 86.07% from a year prior.
  • Treasury Shares was $203000.0 for Q4 2025 at Outset Medical, down from $229000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.6 million in Q4 2022 to a low of $110000.0 in Q4 2021.
  • A 5-year average of $513400.0 and a median of $229000.0 in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: surged 1348.18% in 2022, then tumbled 72.88% in 2023.
  • Outset Medical's Treasury Shares stood at $110000.0 in 2021, then soared by 1348.18% to $1.6 million in 2022, then crashed by 72.88% to $432000.0 in 2023, then tumbled by 46.99% to $229000.0 in 2024, then decreased by 11.35% to $203000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Treasury Shares are $203000.0 (Q4 2025), $229000.0 (Q4 2024), and $432000.0 (Q4 2023).